Trial
NCT06895577
Neoadjuvant Chemoradiotherapy Plus Sintilimab for MSS, Locally Advanced Rectal Cancer-
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Sun Yat-sen University
Collaborators
—
Condition
Rectal Cancer
Intervention
neoadjuvant SCRT followed by Sintilimab plus CAPOX
Why stopped
Due to errors in the previously submitted modification, we request to withdraw it and will submit a corrected update shortly.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-21